β-Hydroxybutyrate: A signaling metabolite in starvation response?

Cellular Signalling

Volumn 28, Issue 8, 2016, Pages 917-923

  Rojas Morales, Pedro ^a   Tapia, Edilia ^b   Pedraza Chaverri, José ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Autophagy; Energy expenditure; Signaling; Starvation; Hydroxybutyrate

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; HISTONE DEACETYLASE; INSULIN; KETONE BODY; SHORT CHAIN FATTY ACID;

AUTOPHAGY; DIET RESTRICTION; ENERGY BALANCE; ENERGY EXPENDITURE; FATTY ACID OXIDATION; FEEDING BEHAVIOR; FOOD DEPRIVATION; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HUMAN; INSULIN RESISTANCE; KETOACIDOSIS; KETOGENESIS; LIFE EXTENSION; LIPOLYSIS; METABOLIC RATE; METABOLIC STRESS; METABOLISM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STARVATION; THERMOGENESIS; ANIMAL; ENERGY METABOLISM;

3-HYDROXYBUTYRIC ACID; ANIMALS; ENERGY METABOLISM; HUMANS; INSULIN; KETONE BODIES; SIGNAL TRANSDUCTION; STARVATION;

EID: 84966309549     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2016.04.005     Document Type: Review

References (97)

1. McCue M.D. Starvation physiology: reviewing the different strategies animals use to survive a common challenge. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2010, 156:1-18.
2. Wang T., Hung C.Y., Randall D.J. The comparative physiology of food deprivation: from feast to famine. Annu. Rev. Physiol. 2006, 68:223-251.
3. Rui L. Energy metabolism in the liver. Compr. Physiol. 2014, 4:177-197.
4. Robinson A.M., Williamson D.H. Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiol. Rev. 1980, 60:143-187.
5. Dedkova E.N., Blatter L.A. Role of beta-hydroxybutyrate, its polymer poly-beta-hydroxybutyrate and inorganic polyphosphate in mammalian health and disease. Front. Physiol. 2014, 5:260.
6. Cahill G.F. Fuel metabolism in starvation. Annu. Rev. Nutr. 2006, 26:1-22.
7. Cotter D.G., Schugar R.C., Crawford P.A. Ketone body metabolism and cardiovascular disease. Am. J. Physiol. Heart Circ. Physiol. 2013, 304:H1060-H1076.
8. Cotter D.G., Ercal B., Huang X., Leid J.M., d'Avignon D.A., Graham M.J., Dietzen D.J., Brunt E.M., Patti G.J., Crawford P.A. Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia. J. Clin. Invest. 2014, 124:5175-5190.
9. Cotter D.G., d'Avignon D.A., Wentz A.E., Weber M.L., Crawford P.A. Obligate role for ketone body oxidation in neonatal metabolic homeostasis. J. Biol. Chem. 2011, 286:6902-6910.
10. Cotter D.G., Schugar R.C., Wentz A.E., d'Avignon D.A., Crawford P.A. Successful adaptation to ketosis by mice with tissue-specific deficiency of ketone body oxidation. Am. J. Physiol. Endocrinol. Metab. 2013, 304:E363-E374.
11. Schugar R.C., Moll A.R., d'Avignon D.A., Weinheimer C.J., Kovacs A., Crawford P.A. Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling. Mol. Metab. 2014, 3:754-769.
12. Blad C.C., Tang C., Offermanns S. G protein-coupled receptors for energy metabolites as new therapeutic targets. Nat. Rev. Drug Discov. 2012, 11:603-619.
13. Chriett S., Pirola L. Essential roles of four-carbon backbone chemicals in the control of metabolism. World J. Biol. Chem. 2015, 6:223-230.
14. Kasubuchi M., Hasegawa S., Hiramatsu T., Ichimura A., Kimura I. Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients 2015, 7:2839-2849.
15. Canfora E.E., Jocken J.W., Blaak E.E. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat. Rev. Endocrinol. 2015, 11:577-591.
16. Newman J.C., Verdin E. Ketone bodies as signaling metabolites. Trends Endocrinol. Metab. 2014, 25:42-52.
17. Newman J.C., Verdin E. Beta-hydroxybutyrate: much more than a metabolite. Diabetes Res. Clin. Pract. 2014, 106:173-181.
18. Zou X., Meng J., Li L., Li C., Zhong R., Miao X., Cai J., Zhang Y., Zhu D. Acetoacetate accelerates muscle regeneration and ameliorates muscular dystrophy in mice. J. Biol. Chem. 2016, 291:2118-2195.
19. Taggart A.K., Kero J., Gan X., Cai T.Q., Cheng K., Ippolito M., Ren N., Kaplan R., Wu K., Wu T.J., Jin L., Liaw C., Chen R., Richman J., Connolly D., Offermanns S., Wright S.D., Waters M.G. (d)-Beta-hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J. Biol. Chem. 2005, 280:26649-26652.
20. Kimura I., Inoue D., Hara T., Ichimura A., Miyauchi S., Kobayashi M., Hirasawa A., Tsujimoto G. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via H protein-coupled receptor 41 (GRP41). Proc. Natl. Acad. Sci. U. S. A. 2011, 108:8030-8035.
21. Shimazu T., Hirschey M.D., Newman J., He W., Shirakawa K., Moan N., Grueter C.A., Lim H., Saunder L.P., Stevens R.D., Newgard C.B., Farese R.V., de Cabo R., Ulrich S., Akassoglou K., Verdin E. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 2013, 339:211-214.
22. Youm Y.H., Nguyen K.Y., Grant R.W., Goldberg E.L., Bodogai M., Dongin K., D'Agostino D., Planavsky N., Lupfer C., Kanneganti T.D., Kang S., Horvath T.L., Fahmy T.M., Crawford P.A., Biragym A., Alnemri E., Dixit V.D. The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat. Med. 2014, 21:263-269.
23. Haces M.L., Hernández-Fonseca K., Medina-Campos O.N., Montiel T., Pedraza-Chaverri J., Massieu L. Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions. Exp. Neurol. 2008, 211:85-96.
24. Wei T., Tian W., Liu F., Xie G. Protective effects of exogenous β-hydroxybutyrate on paraquat toxicity in rat kidney. Biochem. Biophys. Res. Commun. 2014, 447:666-671.
25. Tieu K., Perier C., Caspersen C., Teismann P., Wu D.C., Yan S.D., Naini A., Vila M., Jackson-Lewi V., Ramasamy R., Przedborski S. d-Beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J. Clin. Invest. 2003, 112:892-901.
26. Kim D.Y., Davis L.M., Sullivan P.G., Maalouf M., Simeone T.A., van Brederode J., Rho J.M. Ketone bodies are protective against oxidative stress in neocortical neurons. J. Neurochem. 2007, 101:1316-1326.
27. Suzuki M., Suzuki M., Kitamura Y., Mori S., Sato K., Matsuura A., Hiraide A. Beta-hydroxybutyrate, a cerebral function improving agent, protects rat brain against ischemic damage caused by permanent and transient focal cerebral ischemia. Jpn. J. Pharmacol. 2002, 89:36-43.
28. Kim D.Y., Vallejo J., Rho J.M. Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors. J. Neurochem. 2010, 114:130-141.
29. Kim D.Y., Simeone K.A., Simeone T.A., Pandya J.D., Wilke J.C., Ahn Y., Geddes J.W., Sullivan P.G., Rho J.M. Ketone bodies mediate antiseizure effects through mitochondrial permeability transition. Ann. Neurol. 2015, 78:77-87.
30. Edwards C., Canfield J., Copes N., Rehan M., Lipps D., Bradshaw P.C. d-Beta-hydroxybutyrate extends lifespan in C. elegans. Aging 2014, 6:621-640.
31. Tunaru S., Kero J., Schaub A., Wufka C., Blaukat A., Pfeffer K., Offermanns S. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat. Methods 2003, 9:352-355.
32. Plaisance E.P., Lukasova M., Offermanns S., Zhang Y., Cao G., Judd R.L. Niacin stimulates adiponectin secretion through the GPR109A receptor. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E549-E558.
33. De Pergola G., Cignarelli M., Corso M., Garruti G., Di Paolo S., Giorgino R. d-(-)-beta-hydroxybutyrate inhibits catecholamine-stimulated lipolysis and decreases beta-adrenoceptors' affinity in human fat cells but not in lymphomocytes. Acta Endocrinol. 1990, 122:450-454.
34. Zechner R., Zimmermann R., Eichmann T.O., Kohlmann S.D., Haemmerle G., Lass A., Madeo F. FAT SIGNALS-lipases and lipolysis in lipid metabolism and signaling. Cell Metab. 2012, 15:279-291.
35. Kubota N., Yano W., Kubota T., Yamauchi T., Itoh S., Kumagai H., Kozono H., Takamoto I., Okamoto S., Shiuchi T., Suzuki R., Satoh H., Tsuchida A., Moroi M., Sugi K., Noda T., Ebinuma H., Ueta Y., Kondo T., Araki E., Ezaki O., Nagai R., Tobe K., Terauchi Y., Ueki K., Minokoshi Y., Kadowaki T. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab. 2007, 6:55-68.
36. Gao Z., Yin J., Zhang J., Ward R.E., Martin R.J., Lefevre M., Cefalu W.T., Ye J. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 2009, 58:1509-1517.
37. Brown A.J., Goldsworthy S.M., Barnes A.A., Eilert M.M., Tcheang L., Daniels D., Muir A.I., Wigglesworth M.J., Kinghorn I., Fraser N.J., Pike N.B., Strum J.C., Steplewski K.M., Murdock P.R., Holder J.C., Marshall F.H., Szekeres P.G., Wilson S., Ignar D.M., Foord S.M., Wise A., Dowell S.J. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 2003, 278:11312-11319.
38. Inoue D., Tsujimoto G., Kimura I. Regulation of energy homeostasis by GPR41. Front. Endocrinol. 2014, 5:81.
39. Inoue D., Kimura I., Wakabayashi M., Tsumoto H., Ozawa K., Hara T., Takei Y., Hirasawa A., Ishihama Y., Tsujimoto G. Short-chain fatty acid receptor GPR41-mediated activation of sympathetic neurons involves synapsin 2b phosphorylation. FEBS Lett. 2012, 586:1547-1554.
40. Priyadarshini M., Layden B.T. FFAR3 modulates insulin secretion and global gene expression in mouse islets. Islets 2015, 7.
41. Won Y.J., Lu V.B., Puhl H.L., Ikeda S.R. Beta-hydroxybutyrate modulates N-type calcium channels in rat sympathetic neurons by acting as an agonist for the G-protein-coupled receptor FFA3. J. Neurosci. 2013, 33:19314-19325.
42. Bellahcene M., O'Dowd J.F., Wargent E.T., Zaibi M.S., Hislop D.C., Ngala R.A., Smith D.M., Cawthorne M.A., Stocker C.J., Arch J.R. Male mice that lack the G-protein-coupled receptor GPR41 have low energy expenditure and increased body fat content. Br. J. Nutr. 2013, 109:1755-1764.
43. Cañas X., Sanchis D., Gómez G., Casanovas J.M., Artigas F., Fernández-Lopez J.A., Remesar X., Alemany M. 3-Hydroxybutyrate co-infused with noradrenaline decreases resulting plasma levels of noradrenaline in Wistar rats. J. Exp. Biol. 1997, 200:2641-2646.
44. Cañas X., Fernández-López J.A., Remesar X., Alemany M. 3-Hydroxyburytate inhibits noradrenaline-induced thermogenesis in lean but not in obese Zucker rats. Int. J. Obes. Relat. Metab. Disord. 1998, 22:734-740.
45. Björkman O., Eriksson L.S. Influence of 60-hours fast on insulin-mediated splanchnic and peripheral glucose metabolism in humans. J. Clin. Invest. 1985, 76:87-92.
46. van der Crabben S.N., Allick G., Ackermans M.T., Endert E., Romijin J.A., Sauerwein H.P. Prolonged fasting induces peripheral insulin resistance, which is nor ameliorated by high-dose salicylate. J. Clin. Endocrinol. Metab. 2008, 93:638-641.
47. Boden G. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 2003, 111:121-124.
48. Delarue J., Magnan C. Free fatty acids and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 2007, 10:142-148.
49. Yamada T., Zhang S.J., Westerblad H., Katz A. Beta-hydroxybutyrate inhibits insulin-mediated glucose transport in mouse oxidative muscle. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E364-E373.
50. Ivarsson N., Zhang S.J., Katz A. AICAR reverses ketone body mediated insulin resistance in isolated oxidative muscle. Biochem. Biophys. Res. Commun. 2011, 414:670-674.
51. Tardif A., Julien N., Pelletier A., Thibault G., Srivastava A.K., Chiasson J.L., Goderre L. Chronic exposure to beta-hydroxybutyrate impairs insulin action in primary cultures of adult cardiomyocytes. Am. J. Physiol. Endocrinol. Metab. 2001, 281:E1205-E1212.
52. Palletier A., Tardif A., Gingras M.H., Chiasson J.L., Coderre L. Chronic exposure to ketone bodies impairs glucose uptake in adult cardiomyocytes in response to insulin but not vanadate: the role of PI3-K. Mol. Cell. Biochem. 2007, 296:97-108.
53. Maizels E.Z., Ruderman N.B., Goodman M.N., Lau D. Effect of acetoacetate on glucose metabolism in the soleus and extensor digitorum longus muscles of the rat. Biochem. J. 1977, 162:557-586.
54. Yokoo H., Saitoh T., Shiraishi S., Yanagita T., Sugano T., Minami S., Kobayashi H., Wada A. Distinct effects of ketone bodies on down-regulation of cell surface insulin receptor and insulin receptor substrate-1 phosphorylation in adrenal chromaffin cells. J. Pharmacol. Exp. Ther. 2003, 304:994-1002.
55. McDaniel S.S., Rensing N.R., Thio L.L., Yamada K.A., Wong M. The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway. Epilepsia 2011, 52:e7-e11.
56. Mercken E.M., Crosby S.D., Lamming D.M., JeBailey L., Krzysik-Walker S., Villareal D.T., Capri M., Franceschi C., Zhang Y., Becker K., Sabatini D.M., de Cabo R., Fontana L. Calorie restriction in humans inhibits the PI3K/AKT pathway and induces a younger transcription profile. Aging Cell 2013, 12:645-651.
57. Krook A., Roth R.A., Jiang X.J., Zierath J.R., Wallberg-Henriksson H. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes 1998, 47:1281-1286.
58. Mizushima N., Levine B., Cuervo A.M., Klionsly D.J. Autophagy fights disease through cellular self-digestion. Nature 2008, 451:1069-1075.
59. Kroemer G., Mariño G., Levine B. Autophagy and the integrated stress response. Mol. Cell 2010, 40:280-293.
60. Kaur J., Debnath J. Autophagy at the crossroads of catabolism and anabolism. Nat. Rev. Mol. Cell Biol. 2015, 16:461-472.
61. Feng Y., Yao Z., Klionsky D.J. How to control self-digestion: transcriptional, post-transcriptional, and post-translational regulation of autophagy. Trends Cell Biol. 2015, 25:354-363.
62. Singh R., Cuervo A.M. Autophagy in the cellular energetic balance. Cell Metab. 2011, 13:495-504.
63. Berjano E., Cuervo A.M. Chaperone-mediated autophagy. Proc. Am. Thorac. Soc. 2010, 7:29-39.
64. Finn P.F., Dice J.F. Proteolytic and lipolytic responses to starvation. Nutrition 2006, 22:830-844.
65. Calnan D.R., Brunet A. The foxO code. Oncogene 2008, 27:2276-2288.
66. Mammucari C., Milan G., Romanello V., Masiero E., Rudolf R., Del Piccolo P., Burden S.J., Di Lisi R., Sandri C., Zhao J., Goldberg A.L., Schiaffino S., Sandri M. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 2007, 6:458-471.
67. Zhao J., Brault J.J., Schild A., Cao P., Sandri M., Schiaffino S., Lecker S.H., Goldberg A.L. FoxO3 coordinately activates protein degradation by the autophagic/lysosoml and proteosomal pathways in atrophying muscle cells. Cell Metab. 2007, 6:472-483.
68. Warr M.R., Binnewies M., Flach J., Reynaud D., Garg T., Malhotra R., Debnath J., Passegué E. FOXO3A directs a protective autophagy program in haematopoietic stem cells. Nature 2013, 494:323-327.
69. Schips T.G., Wietelmann A., Höhn K., Schimanski S., Walther P., Braun T., Wirth T., Maier H.J. FoxO3 induces reversible cardiac atrophy and autophagy in a transgenic mouse model. Cardiovasc. Res. 2011, 91:587-597.
70. Lee J.H., Budanov A.V., Park E.J., Birse R., Kim T.E., Perkins G.A., Ocorr K., Ellisman M.H., Bodmer R., Bier E., Karin M. Sestrin as feedback inhibitor of TOR that prevents age-related pathologies. Science 2010, 327:1223-1228.
71. Chen C.C., Jeon S.M., Bhaskar P.T., Nogueira V., Sundararajan D., Tonic I., Park Y., Hay N. FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor. Dev. Cell 2010, 18:592-604.
72. van der Vos K.E., Eliasson P., Proikas-Cezanne T., Vervoort S.J., van Boxtel R., Putker M., van Zutphen I.J., Mauthe M., Zellmer S., Pals C., Verhagen L.P., Groot Koerkamp M.J., Braat A.K., Dansen T.B., Holstege F.C., Gebhardt R., Burgering B.M., Coffer P.J. Modulation of glutamine metabolism by the PI(3)K-PKB-FOXO network regulates autophagy. Nat. Cell Biol. 2012, 14:829-837.
73. He C., Klionsky D.J. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 2009, 43:67-93.
74. Jung C.H., Ro S.H., Cao J., Otto M.N., Kim D.H. mTOR regulation of autophagy. FEBS Lett. 2010, 584:1287-1295.
75. Kim Y.C., Guan K.L. mTOR: a pharmacologic target for autophagy regulation. J. Clin. Invest. 2015, 125:25-32.
76. Ravikumar B., Sarkar S., Davies J.E., Futter M., Garcia-Arencibia M., Green-Thompson Z.W., Jimenez-Sanchez M., Korolchuk V.I., Lichtenberg M., Luo S., Massey D.C., Menzies F.M., Moreau K., Narayanan U., Renna M., Siddiqi F.H., Underwood B.R., Winslow A.R., Rubinsztein D.C. Regulation of mammalian autophagy in physiology and pathology. Physiol. Rev. 2010, 90:1383-1435.
77. Alers S., Löffler A.S., Wesselborg S., Stork B. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol. Cell. Biol. 2012, 32:2-11.
78. Segupta S., Peterson T.R., Laplante M., Oh S., Sabatini D.M. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature 2010, 468:1100-1104.
79. Shao Y., Gao Z., Marks P.A., Jiang X. Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:18030-18035.
80. Robert T., Vanoli F., Chiolo I., Shubassi G., Bernstein K.A., Rothstein R., Botrugno O.A., Parazzoli D., Oldani A., Minucci S., Foiani M. HDACs link the DNA damage response, processing of double-strand breaks and autophagy. Nature 2011, 471:74-79.
81. Gammoh N., Lam D., Puente C., Ganley I., Marks P.A., Jiang X. Role of autophagy in histone deacetylase inhibitor-induced apoptotic and noapoptotic cell death. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:6561-6565.
82. Zhang J., Ng S., Wang J., Zhou J., Tan S.H., Yang N., Lin Q., Xia D., Shen H.M. Histone deacetylase inhibitors induce autophagy through FOXO1-dependent pathways. Autophagy 2015, 11:629-642.
83. Koeneke E., Witt O., Oehme I. HDAC family members intertwined in the regulation of autophagy: a druggable vulnerability in aggressive tumor entities. Cell 2015, 4:135-168.
84. Hay N. Interplay between FOXO, TOR, and Akt. Biochim. Biophys. Acta 2011, 1813:1965-1970.
85. Camberos-Luna L., Gerónimo-Olvera C., Motiel T., Rincon-Heredia R., Massieu L. The ketone body, beta-hydroxybutyrate stimulates the autophagic flux and prevents neuronal death induced by glucose deprivation in cortical cultured neurons. Neurochem. Res. 2016, 41:600-609.
86. Finn P.F., Dice J.F. Ketone bodies stimulate chaperone-mediated autophagy. J. Biol. Chem. 2005, 280:25864-25870.
87. Rahman M., Muhammad S., Khan M.A., Chen H., Ridder D.A., Müller-Fielitz H., Pokorná B., Vollbrandt T., Stölting I., Nadrowitz R., Oku J.G., Offermanns S., Schwaninger M. The beta-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages. Nat. Commun. 2014, 5:3944.
88. Fu S.P., Li S.N., Wang J.F., Li Y., Xie S.S., Xue W.J., Liu H.M., Huang B.X., Lv Q.K., Lei L.C., Liu G.W., Wang W., Liu J.X. BHBA suppresses LPS-induced inflammation in BV-2 cells by inhibiting NF-kB activation. Mediat. Inflamm. 2014, 2014:983401.
89. Fu S.P., Wang J.F., Xue W.J., Liu H.M., Liu B.R., Zeng Y.L., Li S.N., Huang B.X., Lv Q.K., Wang W., Liu J.X. Anti-inflammatory effects of BHBA in both in vivo and vitro Parkinsin's disease models are mediated by GPR109A-dependent mechanisms. J. Neuroinflammation 2015, 12:9.
90. Singh N., Gurav A., Sivaprakasam S., Brady E., Padia R., Shi H., Thangaraju M., Prasad P.D., Manicassamy S., Munn D.H., Lee J.R., Offermanns S., Ganapathy V. Activation of Grp109a, receptor for niacin and commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 2014, 40:128-139.
91. Ye J., Keller J.N. Regulation of energy metabolism by inflammation: a feedback response in obesity and caloric restriction. Aging 2010, 2:361-368.
92. Wang H., Ye J. Regulation of energy balance by inflammation: common theme in physiology and pathology. Rev. Endocr. Metab. Disord. 2015, 16:47-54.
93. Lumeng C.N., Saltiel A.R. Inflammation links between obesity and metabolic disease. J. Clin. Invest. 2011, 121:2111-2117.
94. Johnson A.R., Milner J.J., Makowski L. The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol. Rev. 2012, 249:218-238.
95. Febbraio M.A. Role of interleukins in obesity: implications for metabolic disease. Trends Endocrinol. Metab. 2014, 25:312-319.
96. Laeger T., Merges C.C., Kuhla B. Role of beta-hydroxybutyric acid in the central regulation of energy balance. Appetite 2010, 54:450-455.
97. Paoli A., Bosco G., Camporesi E.M., Mangar D. Ketosis, ketogenic diet and food intake control: a complex relationship. Front. Psychol. 2015, 6:27.